Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients

Summary There are few studies addressing survival of diffuse peritoneal mesotheliomas (DPM). In this study, survival data were obtained retrospectively from 73 patients treated with intended cytoreductive surgery for DPM, with a mean follow-up of 42 months. Mesotheliomas were classified as well differentiated papillary (WDPM, n = 2), multicystic (MCM, n = 4), and epithelioid mesotheliomas were subclassified as tubulopapillary (TPM, n = 27), solid/deciduoid (S/DM, n = 34), and or biphasic mesothelioma (BPM, n = 6). Invasion was characterised as absent (grade 0), into stroma (grade 1), into fat (grade 2), and into adjacent structures (grade 3). Peritoneal cancer index (PCI) and completeness of cytoreduction (CCR) were assessed surgically. There were no deaths in the WDPM, MCM, and epithelioid DPM with ⩽ grade 1 invasion. There was a stepwise decrease in overall survival from invasive TPM, S/DM, and BPM (p < 0.0001). By univariate analysis, advanced age (p = 0.01), incomplete CCR (p < 0.001), PCI (p = 0.004), mitotic count (p < 0.001), nuclear grade (p < 0.0001), stromal inflammation (p = 0.013), depth of invasion (p < 0.0001), necrosis (p = 0.002), and sarcomatoid growth (p < 0.0001) were associated with decreased overall survival. By multivariate analysis, only sarcomatoid growth (p = 0.0006), depth of invasion (p = 0.02), elevated CCR (CCR 2–3) (p = 0.02), and presence of inflammatory stroma (p = 0.04) were significant variables associated with decreased overall survival. DPM form a spectrum of indolent to highly aggressive tumours. Solid epithelioid/deciduoid tumours have a prognosis intermediate between biphasic mesotheliomas and invasive TPM. The presence and degree of invasion, sarcomatoid features, and inflammatory stroma are poor prognostic indicators.

[1]  T. Farrell,et al.  A Recurrence of Benign Multicystic Peritoneal Mesothelioma Treated Through Laparoscopic Excision: A Case Report and Review of the Literature , 2014, Surgical laparoscopy, endoscopy & percutaneous techniques.

[2]  R. Pigalarga,et al.  Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature , 2014, BMJ Case Reports.

[3]  K. Mazaz,et al.  Benign cystic mesothelioma of the peritoneum: a case report and literature review , 2013, World Journal of Emergency Surgery.

[4]  R. Bertulli,et al.  Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). , 2013, European journal of cancer.

[5]  A. Burke,et al.  Diffuse mesothelioma of the peritoneum: a pathological study of 64 tumours treated with cytoreductive therapy , 2013, Pathology.

[6]  Y. Kameda,et al.  Well‐differentiated papillary mesothelioma, possibly giving rise to diffuse malignant mesothelioma: A case report , 2013, Pathology international.

[7]  Jian Wang,et al.  Well‐differentiated papillary mesothelioma: a clinicopathological and immunohistochemical study of 18 cases with additional observation , 2013, Histopathology.

[8]  M. C. Pai,et al.  Multicystic peritoneal mesothelioma: not always a benign disease. , 2013, Singapore medical journal.

[9]  A. Malpica,et al.  Well-Differentiated Papillary Mesothelioma of the Female Peritoneum: A Clinicopathologic Study of 26 Cases , 2012, The American journal of surgical pathology.

[10]  T. Chua,et al.  Multi‐institutional experience of diffuse intra‐abdominal multicystic peritoneal mesothelioma , 2011, The British journal of surgery.

[11]  M. Vaira,et al.  Multicystic peritoneal mesothelioma: outcomes and patho-biological features in a multi-institutional series treated by cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[12]  T. Chua,et al.  Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  D. Nonaka,et al.  Multicystic and Well-differentiated Papillary Peritoneal Mesothelioma Treated by Surgical Cytoreduction and Hyperthermic Intra-peritoneal Chemotherapy (HIPEC) , 2007, Annals of Surgical Oncology.

[14]  M. Frego,et al.  Peritoneal mesothelioma: a review. , 2007, MedGenMed : Medscape general medicine.

[15]  P. Sugarbaker,et al.  A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  E. Brun,et al.  Prognostic significance of histomorphologic parameters in diffuse malignant peritoneal mesothelioma. , 2006, Archives of pathology & laboratory medicine.

[17]  P. Casali,et al.  Diffuse malignant mesothelioma of the peritoneum , 2005, Cancer.

[18]  P. Clement,et al.  Malignant Peritoneal Mesothelioma in Women , 2005 .

[19]  P. Clement,et al.  Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. , 2005, American journal of clinical pathology.

[20]  Seth M Steinberg,et al.  Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  G. Georgiadis,et al.  Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[22]  D. Elias,et al.  Peritoneal Cystic Mesothelioma: A Case Series , 2003, Tumori.

[23]  Huichang Yan,et al.  Malignant transformation of “benign” cystic mesothelioma of the peritoneum , 2002, Journal of surgical oncology.

[24]  V. Roggli,et al.  Well-Differentiated Papillary Mesothelioma , 2001, The American journal of surgical pathology.